Mirion Technologies, Inc. (NYSE:MIR) Receives $28.38 Consensus Target Price from Analysts

Shares of Mirion Technologies, Inc. (NYSE:MIR) have earned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $28.3750.

Several equities research analysts have recently commented on MIR shares. Citigroup lowered their price target on shares of Mirion Technologies from $35.00 to $33.00 and set a “buy” rating for the company in a research report on Monday, December 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mirion Technologies in a report on Wednesday, October 8th. JPMorgan Chase & Co. upped their target price on shares of Mirion Technologies from $28.00 to $34.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. Morgan Stanley began coverage on Mirion Technologies in a research report on Friday, January 23rd. They issued an “equal weight” rating and a $29.00 price target on the stock. Finally, Evercore ISI assumed coverage on Mirion Technologies in a research note on Tuesday, November 25th. They set an “outperform” rating and a $29.00 price objective for the company.

Mirion Technologies Price Performance

Mirion Technologies stock opened at $24.93 on Friday. The business’s 50-day simple moving average is $25.07 and its 200 day simple moving average is $23.88. The company has a quick ratio of 4.32, a current ratio of 4.83 and a debt-to-equity ratio of 0.63. The stock has a market cap of $6.33 billion, a price-to-earnings ratio of 226.61 and a beta of 0.97. Mirion Technologies has a 12-month low of $12.00 and a 12-month high of $30.28.

Insider Activity at Mirion Technologies

In other Mirion Technologies news, Director Lawrence D. Kingsley sold 350,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 10th. The shares were sold at an average price of $24.73, for a total transaction of $8,655,500.00. Following the sale, the director directly owned 3,509,075 shares in the company, valued at approximately $86,779,424.75. This trade represents a 9.07% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 2.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Tudor Investment Corp ET AL raised its stake in Mirion Technologies by 174,900.0% in the third quarter. Tudor Investment Corp ET AL now owns 17,500,000 shares of the company’s stock valued at $407,050,000 after purchasing an additional 17,490,000 shares in the last quarter. Vanguard Group Inc. increased its holdings in Mirion Technologies by 28.0% in the 3rd quarter. Vanguard Group Inc. now owns 30,418,327 shares of the company’s stock valued at $707,530,000 after buying an additional 6,651,735 shares during the period. Two Creeks Capital Management LP bought a new position in Mirion Technologies in the 3rd quarter valued at about $83,707,000. UBS Group AG raised its position in shares of Mirion Technologies by 181.4% in the 3rd quarter. UBS Group AG now owns 4,796,833 shares of the company’s stock valued at $111,574,000 after buying an additional 3,092,136 shares in the last quarter. Finally, Invesco Ltd. lifted its holdings in shares of Mirion Technologies by 713.2% during the 2nd quarter. Invesco Ltd. now owns 2,617,252 shares of the company’s stock worth $56,349,000 after acquiring an additional 2,295,414 shares during the period. Institutional investors and hedge funds own 78.51% of the company’s stock.

Mirion Technologies Company Profile

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.